Parameter | Estrogens group* (n = 29) | Placebo group (n = 29) |
---|---|---|
Any adverse events | 15 (51.72%) | 12 (41.38%) |
 Breast tenderness | 9 (31.03%) | 7 (28.00%) |
 Vaginal discharge | 4 (13.79%) | 4 (13.79%) |
 Insoluble pill | 7 (24.14%) | 4 (13.79%) |
 New onset of vaginal itching | 4 (13.79%) | 0 (0%) |